UBS Lifts Kenvue Price Target to $19 After Q4 Results, Keeps Neutral Rating
UBS raised its 12-month price target on Kenvue Inc. to $19 from $17 while maintaining a Neutral rating following the company's fourth-quarter results that exceeded expectations. The beat was driven by stronger organic sales, improved margins and a favorable tax rate, but management withheld a 2026 outlook because of the pending acquisition by Kimbe…